Background: Mycobacterium tuberculosis (Mtb) infects approximately one third of the world's population, 10% of which develop disease during lifetime. Beijing genotype strains are the most predominant strains in China. The aim of this study was to screen and validate the possible HLA*0201 restricted specific T cell epitopes of latent phase Mtb strains H37Rv and Beijing genotype.
Background: Drug-resistant tuberculosis is a major public health threat. High mortality rates have been reported for patients with extensively drug-resistant tuberculosis (XDR TB), particularly in the case of co-infection with HIV. Early South-African reports tallied a near-100% mortality rate in the Tugela Ferry outbreak (Gandhi et al. Lancet 2006) ; pooled data from various institutions from South Africa including Sizwe Hospital reported an overall mortality rate for XDR-TB patients after initiation of therapy of 36% (Dheda et al. Lancet 2010).
Methods & Materials: This is a retrospective sub-analysis of case records of adult patients treated for XDR TB (culture confirmed), who were all admitted toSizweHospitalinJohannesburg,South Africa, between June 2004 and September 2008. Endpoints used were mortality and sputum culture conversion (defined as at least two consecutive negative cultures).
Results: Thirty-three patients for which comprehensive information was available from the case records were included in the analysis. The majority of patients was male (18/33, 54.5%) with a mean age of 39.6 years (95% CI 31.9-41.8). HIV infection was present in 22/33 (66.7%) individuals. Individuals were followed for a median time of 11.8 months (IQR 9.1 months). Five of these patients died (5/33, 15.2%), after a median time of 6.3 months (95% CI 2.0-10.5 months); 4 of them were HIV positive (4/5, 80%). Sputum culture conversion occurred in 10 individuals (10/33, 30.3%), after a median time of 12.2 months (95% CI 3.9-24.8 months).
Conclusion: In a specialized hospital setting, mortality rates for XDR TB patients can be considerably reduced well below a 20% mortality threshold. http://dx.doi.org/10.1016/j.ijid.2014.03.1055
